5-hydroxymethylomeprazole has been researched along with warfarin in 1 studies
| Studies (5-hydroxymethylomeprazole) | Trials (5-hydroxymethylomeprazole) | Recent Studies (post-2010) (5-hydroxymethylomeprazole) | Studies (warfarin) | Trials (warfarin) | Recent Studies (post-2010) (warfarin) |
|---|---|---|---|---|---|
| 54 | 17 | 15 | 36,573 | 2,143 | 14,728 |
| Protein | Taxonomy | 5-hydroxymethylomeprazole (IC50) | warfarin (IC50) |
|---|---|---|---|
| Vitamin K epoxide reductase complex subunit 1 | Homo sapiens (human) | 0.0088 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bertilsson, L; Eliasson, E; Masquelier, M; Ostervall, J; Otto, S; Rosenborg, S; Stenberg, M; Yue, QY | 1 |
1 trial(s) available for 5-hydroxymethylomeprazole and warfarin
| Article | Year |
|---|---|
Clinically significant CYP2C inhibition by noscapine but not by glucosamine.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anticoagulants; Antitussive Agents; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C9; Drug Interactions; Female; Glucosamine; Humans; Losartan; Male; Middle Aged; Noscapine; Omeprazole; Phenotype; Warfarin; Young Adult | 2010 |